一种选择性多巴胺激动剂,正在考虑用于全身性高血压的非肠道治疗。口服和非肠道用药时,这种化合物都能通过刺激多巴胺-1 肾上腺素能受体使外周血管扩张。与硝普钠相比,静脉注射非诺多泮可能更具优势,因为它既能诱导利尿,也能诱导利钠。它对光不敏感,也不会产生氰化物毒性。没有证据表明停止输注非诺多泮后会出现反跳性高血压。
Fenoldopam monohydrobromide (CAS 67287-54-1) 参考文献
Hahn, R.A., et al., Characterization of the peripheral and central effects of SK&F 82526a novel dopamine receptor agonist. J. Pharmacol. Exp. Ther. 223, 305-313, (1982) Hussain, T., and Lokhandwala, M.F., Renal dopamine DA1 receptor coupling with G(S) and G(q/11) proteins in spontaneously hypertensive rats. Am. J. Physiol. 272, F339-F346, (1997) Venkatakrishnan, U., et al., The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation. Clin. Exp. Hypertens. 22, 309-324, (2000) Quevedo, M., et al., The effect of fenoldopam on the blood pressure of the rat. Gen. Pharmacol. 32, 123-125, (1999) deVries, P.A., et al., Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 34, 191-198, (1999)